In a 22-year-old male presenting with fever, frequent belching, right mid‑sternal (epigastric) pain, no abdominal pain, and normal bowel movements, what is the most likely diagnosis and the appropriate treatment regimen with dosages?

Diagnosis and Treatment

This 22-year-old male most likely has acute gastritis or peptic ulcer disease, potentially related to Helicobacter pylori infection, and should be started empirically on bismuth quadruple therapy for 14 days while arranging H. pylori testing.

Clinical Reasoning

The presentation of fever, frequent belching (eructation), and right mid-sternal (epigastric) pain in a young adult with normal bowel movements points toward upper gastrointestinal pathology. The combination of fever with epigastric pain raises concern for H. pylori-associated gastritis or peptic ulcer disease 1. The absence of lower abdominal pain and normal stool passage makes lower GI pathology less likely.

Diagnostic Approach

Key steps:

• Test for H. pylori infection using either:
  • Urea breath test (preferred non-invasive)
  • Stool antigen test
  • Serology (less preferred)
• Consider endoscopy if alarm symptoms develop (weight loss, bleeding, persistent vomiting, dysphagia)
• Rule out NSAID use as contributing factor

Treatment Regimen

First-Line Therapy: Bismuth Quadruple Therapy (14 days)

The recommended empiric treatment is bismuth quadruple therapy, which achieves >90% eradication rates and does not require susceptibility testing 2, 3:

• Bismuth subsalicylate: 300 mg four times daily (qid)
• Metronidazole: 500 mg three times daily (tid) with food
• Tetracycline: 500 mg four times daily (qid)
• Proton pump inhibitor (PPI):
  • Esomeprazole 40 mg OR Rabeprazole 40 mg twice daily (bid)
  • Take 30 minutes before meals on empty stomach
  • These are preferred over pantoprazole due to superior potency 2, 3

Duration: 14 days 3

Alternative First-Line Option: Rifabutin Triple Therapy

If bismuth quadruple therapy is unavailable or not tolerated 2, 3:

• Rifabutin: 150 mg twice daily
• Amoxicillin: 1 g three times daily (divided dosing critical to maintain levels) 3
• Esomeprazole or Rabeprazole: 40 mg twice daily, 30 minutes before meals

Duration: 14 days

Critical Implementation Points

PPI optimization is essential 3:

• Higher-potency PPIs (esomeprazole, rabeprazole) are superior to omeprazole or pantoprazole
• Twice-daily dosing mandatory
• Must be taken 30 minutes before eating on empty stomach
• Avoid concurrent H2-blockers which interfere with PPI activation

Metronidazole considerations 3:

• Divide doses (tid-qid) and take with food to improve tolerability
• Warn patient to avoid alcohol completely during treatment (disulfiram-like reaction)
• Higher doses (1.5-2 g/day) overcome resistance when combined with bismuth

Amoxicillin dosing 3:

• Must be divided into at least 3 doses daily to avoid low trough levels
• Total daily dose: 2-3 grams

Common Pitfalls to Avoid

1. Do NOT use clarithromycin-based triple therapy empirically - resistance rates are too high in most regions 2, 3
2. Do NOT use levofloxacin empirically - should only be used with proven susceptibility 3
3. Do NOT underdose the PPI - standard dose is insufficient; use high-potency PPIs at double standard doses 2, 3
4. Do NOT use 7-day regimens - 14 days significantly improves eradication rates 3

Follow-Up

• Confirm H. pylori eradication 4+ weeks after completing antibiotics using urea breath test or stool antigen (NOT serology)
• If symptoms persist despite treatment, proceed to endoscopy
• If first treatment fails with confirmed adherence, consider susceptibility testing before second attempt 3

Symptomatic Management

While awaiting H. pylori test results or during treatment:

• Continue PPI therapy for symptom relief
• Avoid NSAIDs, alcohol, and smoking
• Small, frequent meals may help reduce symptoms